The Children’s Tumor Foundation is delighted to announce our co-sponsorship of the third “State of the Art” International NF2 Conference to be held at the Manchester Conference Center, United Kingdom, May 21-22, 2012. The meeting will be hosted by the Manchester University NF2 Multidisciplinary Team.
The “State of the Art” meeting is a key event for the NF2 clinical and research community. Past “State of the Art” meetings were held in Paris (2006) and Las Vegas (2010) and attracted attendance by the world leadership of NF2 clinical care, scientific and translational research, and clinical trials. The 2012 meeting will focus on Epidemiology, Genetics and Natural History of NF2, NF2 Surgery and Radiosurgery, Auditory Rehabilitation and Animal Models and preclinical and clinical trials.
Given the tremendous progress made in NF2 research and clinical trials in recent years we anticipate a very exciting meeting in 2012! As with previous “State of the Art” meetings, the aim is to encourage discussion in a relaxed setting, and Manchester is sure to provide a unique venue.
For more information: http://www.nf2international2012.co.uk/
